What is Vir Biotechnology, Inc.'s investment proceeds?

Vir Biotechnology, Inc. (VIR) reported investment proceeds of $170.6M in Q1 2026.

How has Vir Biotechnology, Inc.'s investment proceeds changed year-over-year?

Vir Biotechnology, Inc.'s investment proceeds decreased by 43.5% year-over-year, from $301.86M to $170.6M.

What is the long-term trend for Vir Biotechnology, Inc.'s investment proceeds?

Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s investment proceeds has grown at a 41.3% compound annual growth rate (CAGR), from $301.24M to $1.2B.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Vir Biotechnology, Inc. VIR Investment Proceeds

Investment Proceeds at other companies

Iovance Biotherapeutics, Inc.IOVA

$74M-38.3%

Viridian Therapeutics, Inc.VRDN

$168.6M-1.6%

BiohavenBHVN

$35M-83.3%

Arbutus Biopharma CorporationABUS

$16M-65.3%

Avalo TherapeuticsAVTX

$25.51M—

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.67B+130%

Enterprise value$1.48B+228%

P/S25.4×-9.2×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s investment proceeds?: Vir Biotechnology, Inc. (VIR) reported investment proceeds of $170.6M in Q1 2026.
How has Vir Biotechnology, Inc.'s investment proceeds changed year-over-year?: Vir Biotechnology, Inc.'s investment proceeds decreased by 43.5% year-over-year, from $301.86M to $170.6M.
What is the long-term trend for Vir Biotechnology, Inc.'s investment proceeds?: Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s investment proceeds has grown at a 41.3% compound annual growth rate (CAGR), from $301.24M to $1.2B.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.